Ceryvyn Therapeutics LimitedASX: CYV

Appendix 4E and 2026 Annual Report

· Issued by Ceryvyn Therapeutics Limited via ASX

Filed with ASX ·

Ceryvyn Therapeutics Limited Appendix 4E Preliminary final report 1. Company details Name of entity: Ceryvyn Therapeutics Limited (formerly known as Opthea Limited) ABN: 32 006 340 567 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 ...

View Attachment

6ix hasn’t read this filing yet.

Ceryvyn Therapeutics Limited on 6ix

Earlier from Ceryvyn Therapeutics

Later from Ceryvyn Therapeutics

All Ceryvyn Therapeutics news releases